487 followers
21,607 followers
Rx failures w/ nonmedical switching of biosimilars may be Nocebo effect. 140 #RA pts, 51 non-switchers & 89 switchers. Non-switchers more likely to improve than switchers (68 vs 26%, p < 0.001) and less likely to worsen (1% vs 9%, p < 0.01). http
1,419 followers
These authors hypothesised that the real-world outcomes of patients with RA receiving the adalimumab (ADA) bio-originator with those of patients who switched from the ADA bio-originator to an ADA biosimilar would differ. Read the results here: https://t.co